Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis

Cancer Letters

Volumn 134, Issue 2, 1998, Pages 181-186

  Koike, Kazuhiko ^a   Moriya, Kyoji ^a   Yotsuyanagi, Hiroshi ^a   Shintani, Yoshizumi ^a   Fujie, Hajime ^a   Tsutsumi, Takeya ^a   Kimura, Satoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; HBx gene; Hepatitis B virus; Hepatocellular carcinoma

Indexed keywords

PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE; HEPATITIS B VIRUS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AGING; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; IN SITU NICK-END LABELING; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, TRANSGENIC; PHENOTYPE; PRECANCEROUS CONDITIONS; TRANS-ACTIVATORS;

EID: 0032418235     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00252-3     Document Type: Article

References (27)

1. Columbano A., Ledda-Columbano G.M., Ennas M.G., Curto M., Chelo A., Pani P. Occurrence of cell death (apoptosis) during involution of liver hyperplasia. Lab. Invest. 52:1985;670-677.
2. Bursch W., Lauer B., Timmermann-Trosiener I., Barthel G., Schuppler J., Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis. 5:1984;543-547.
3. Bursch W., Taper H.S., Lauer B., Schulte-Hermann R. Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. 50:1985;153-166.
4. Teissitore L., Valente G., Bonelli G., Costelli P., Bacciono F.M. Regulation of cell turnover in the livers of tumor-bearing rats: occurrence of apoptosis. Int. J. Cancer. 44:1989;697-700.
5. Zerban H., Radig S., Kopp-Schneider A., Bannasch P. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis. 15:1994;2467-2473.
6. Twu J.S., Chu K., Robinson W.S. Hepatitis B virus X gene activates kB-like enhancer sequences in the long terminal repeat of immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA. 86:1989;5168-5172.
7. Balsano C., Avantaggiati M.L., Natoli G., De Marzio E., Will H., Perricaudet M., Levrero M. Full-length and truncated versions of the hepatitis B virus x protein transactivate the c-myc protooncogene at the transcriptional level. Biochem. Biophys. Res. Commun. 176:1991;985-992.
8. Twu J.S., Lai M.Y., Chen D.S., Robinson W. Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology. 192:1993;346-350.
9. Kim C.M., Koike K., Saito I., Miyamura I., Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature. 351:1991;317-320.
10. Koike K., Moriya K., Iino S., Yotsuyanagi H., Endo Y., Miyamura T., Kurokawa K. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19:1994;810-819.
11. Wang W., London W.T., Feitelson M.A. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res. 51:1991;4971-4977.
12. Zhu M., London W.T., Duan L.X., Feitelson M.A. The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma. Int. J. Cancer. 55:1993;571-576.
13. Diamantis I.D., McGandy C.E., Chen T.-J., Liaw Y.-F., Gudat F., Bianchi L. Hepatitis B X-gene expression in hepatocellular carcinoma. J. Hepatol. 15:1992;400-403.
14. Paterlini P., Poussin K., Kew M., Franco D., Brechot C. Selective accumulation of the x transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology. 21:1995;313-321.
15. Koike K. Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology. 38:1995;134-142.
16. Koike K., Moriya K., Yotsuyanagi H., Iino S., Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. Clin. Invest. 94:1994;44-49.
17. Benn J., Schneider R.J. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad. Sci. USA. 92:1995;11215-11219.
18. Gavrieli Y., Sherma Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear fragmentation. J. Cell. Biol. 119:1992;493-501.
19. Chirillo P., Paganp S., Natoli G., Puri P.L., Burgio V.L., Balsano C., Levrero M. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc. Natl. Acad. Sci. USA. 94:1997;8162-8167.
20. Ueda H., Ullrich S.J., Gangemi J.D., Kappel C.A., Ngo L., Feitelson M.A., Jay G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet. 9:1995;41-47.
21. Feitelson M.A., Zhu M., Duan L.X., London W.T. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene. 8:1993;1109-1117.
22. Wang X.W., Forrester K., Yeh H., Feitelson M.A., Gu J.R., Harris C.C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity and association with transcriptional factor ERCC3. Proc. Natl. Acad. Sci. USA. 91:1994;2230-2234.
23. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
24. Sinn E., Muller W., Pattengale P., Tepler I., Wallace R., Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell. 49:1987;465-475.
25. Sepulveda A.R., Finegold M.J., Smith B., Slagel B.L., DeMayo J.L., Shen R.F., Woo S.L.C., Butel J. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human α-1-antitrypsin gene. Cancer Res. 49:1989;6108-6117.
26. Held W.A., Mullins J.J., Kuhn N.J., Gallagher J.F., Gu G.D., Gross K.W. T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene. EMBO J. 8:1989;183-191.
27. Sandgren E.P., Quaife C.J., Pinkert C.A., Palmiter R.D., Brinster R.L. Oncogene-induced liver neoplasia in transgenic mice. Oncogene. 4:1989;715-724.